I would not go to ACHN, IMO. If you complain about ACAD's management then ACHN is not for you. Deshpande et al. are terrible. Bad communication, months and months of nothing and just dilution. And of course they will not hesitate to give themselves more options. Plus, HCV franchise despite being really lucrative, you have seen GILD last quarter not so good and Janssen (Olysio and 3102) are late to the party. And you are left with Factor D which is years away.